Table 1.
Patients’ characteristics. “/” indicates no available data.
| Characteristics | Turin Cohort | Rome Cohort | Total | p-Value |
|---|---|---|---|---|
| n° patients | 227 | 89 | 316 | |
| Age (year), median (IQR) | 46 (39–51) | 45 (37.5–53) | 44 (37.5–49) | 0.867 |
| Caucasian ethnicity, n (%) | 184 (81.1) | 72 (80.9) | 256 (81) | 0.003 |
| Male sex, n (%) | 177 (78) | 85 (95.5) | 262 (82.9) | <0.001 |
| Viral load (copies/mL), median (IQR) | 75.5 (28.8–34.8) | / | 75.5 (28.8–34.8) | / |
| CD4 (cells/mL), median (IQR) | 717 (553.3–870.0) | 546 (408.5–685.5) | 584 (450–746) | <0.001 |
| Vitamin D levels (ng/mL), median (IQR) | 22.3 (15.1–31.2) | 21.9 (16.1–28.8) | 22.3 (15.5–30.3) | 0.657 |
| Deficiency (≤10 ng/mL), n (%) | 23 (10.1) | 11 (12.4) | 34 (10.8) | 0.565 |
| Insufficiency (11–30 ng/mL), n (%) | 143 (63) | 61 (68.5) | 204 (64.6) | 0.333 |
| Sufficiency (>30 ng/mL), n (%) | 61 (26.9) | 17 (19.1) | 78 (24.7) | 0.339 |
| Vitamin D supplementation, n (%) | 17 (7.85) | / | 17 (7.5) | / |